Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial
Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.
Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study locations section was restructured to add state-level headings for New South Wales, Queensland, Victoria, and Western Australia and to remove the previous state subsections, with the page revision updated to v3.3.3.SummaryDifference0.6%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0. No study content or user-facing features appear to be affected.SummaryDifference0.1%
- Check48 days agoChange DetectedThe notice about government funding lapses and NIH operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check63 days agoChange DetectedNo changes detected to core content on the Study Details page (NCT01966029). Eligibility criteria, study endpoints, and other key information remain the same.SummaryDifference0.4%
- Check91 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%
- Check98 days agoChange DetectedUpdated the disorder name capitalization and bumped the revision to v3.1.0 to reflect a version update.SummaryDifference0.1%
Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.